FindTrial
Sign In

Evaluation of 62Cu-ATSM PET/CT in carbon ion  radiotherapy to refractory cancer

Evaluation of 62Cu-ATSM PET/CT in carbon ion  radiotherapy to refractory cancer - ATSM clinical study for refractory cancer 1

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005436
Enrollment
100
Registered
2011-04-13
Start date
2011-05-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, Head and neck cancer

Interventions

62Cu-ATSM and 18FDG PET imaging

Sponsors

National Institute of Radiological Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Lung cancer and head and neck cancer patients planned for carbon ion radiotherapy at NIRS

Exclusion criteria

Exclusion criteria: Patients regarded as unsuitable by principle investigators

Design outcomes

Primary

MeasureTime frame
Qualitative and semi-quantitative assessment of tumor uptake on 62Cu-ATSM and FDG PET images.—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026